Latest News
-
Historic research achievement
Posted on:
Leading Royal North Shore Hospital clinician researcher Associate Professor Brendon Neuen has had three major studies published in the world’s three most prestigious medical journals on the same day – in a rare achievement in clinical research. A/Professor Neuen led the research showing that a new medication protects the kidneys, reduces heart risks, and improves…
Primary Research Area/s:
-
Innovative cancer clinical trials unit unveiled
Posted on:
Researchers from the Kolling Institute will help progress the latest cancer treatments following the official opening of an early phase clinical trials unit at Royal North Shore Hospital. The early phase unit of the NORTH STAR Van Norton Poche Cancer Trials Centre is a dedicated facility to meet the needs of patients and their carers,…
Primary Research Area/s:
-
Recognition for invaluable support
Posted on:
The Kolling Institute hosted a special event to acknowledge NSLHD Board Chair Trevor Danos AM, who is stepping down after 10 years in the role. Trevor has been a tireless advocate for the Kolling, championing research excellence across the Royal North Shore Hospital campus. He provided leadership during an important period for the institute, delivering…
Primary Research Area/s:
-
New research to help detect silent heart disease before it turns deadly
Posted on:
A major research initiative is set to reshape how heart attacks are prevented by detecting heart disease earlier before it leads to a life-threatening event. Interventional cardiologist and leading researcher Professor Gemma Figtree will lead the three-year program after receiving more than $750,000 from the NSW Government. Coronary artery disease remains the leading cause of…
Primary Research Area/s:
-
Recognition for excellence in research
Posted on:
In a sign of the emerging research talent across northern Sydney, a group of impressive up-and-coming investigators have taken out a host of coveted awards at a special event at the Kolling Institute. More than 75 people attended the HDR/ECR Research Forum, which showcased outstanding research across neuroscience and pain, cardiology and renal, cancer and…
Primary Research Area/s:
-
Kolling NEWS – May feature
Posted on:
Check out our Kolling Institute newsletter – profiling the latest impactful research across the Kolling. It’s an insight into the talented investigators behind the scenes, and their exciting progress to improve the care we all receive. Our researchers are driving investigations into new cancer therapies, diabetes, and painful, musculoskeletal conditions, and crucially, developing new life-changing…
Primary Research Area/s:
-
Major investment to improve heart health
Posted on:
Heart Research Australia has committed more than a million dollars to support cardiac research at the Kolling Institute and Royal North Shore Hospital, funding a mix of new and continuing projects across the campus. The investment will support 10 new research grants and the continuation of six existing projects, strengthening clinical and lab-based cardiovascular research…
Primary Research Area/s:
-
Unique expertise draws patients from across the world
Posted on:
For many people living with Meniere’s disease, there’s a tremendous sense of isolation and plenty of challenges accessing the latest, accurate information – that’s why 58 year old Camilla Bjerke flew more than 15,000 kilometres to Sydney to meet with the Kolling Institute’s Professor Jose Antonio Lopez-Escamez. The professor heads the Meniere’s Disease Neuroscience Group,…
Primary Research Area/s:
-
2026 Beryl and Jack Jacobs Travel Awards announced
Posted on:
A collection of five early-to-mid career researchers will share close to $40,000 in funding through the Skipper Jacobs Charitable Trust. The Skipper family has generously supported emerging research talent at the Kolling Institute for many years, providing invaluable travel and career opportunities. This year’s group has welcomed the chance to travel internationally, meet with research…
Primary Research Area/s:
-
Funds to deliver game-changing approach to cancer screening and treatment
Posted on:
Researchers at the Kolling Institute have been awarded significant funding to embed an innovative technique for cancer diagnosis and treatment into healthcare across New South Wales. Delivered by the Cancer Institute NSW, the $3.75 million Translational Program Grant has been awarded to leading clinician and University of Sydney researcher Professor Anthony Gill to test and…
Primary Research Area/s:
